Expert Guide: Lumbar Puncture and CSF Testing - A Key Step in Detecting CNS Leukemia
Summary: Central nervous system leukemia (CNS leukemia) is one of the most common extramedullary manifestations of acute lymphoblastic leukemia. Examining cerebrospinal fluid (CSF) obtained by lumbar puncture is a key part of diagnosis. This article explains five major types of CSF testing - routine analysis, biochemical testing, cytomorphology, flow cytometry, and molecular testing - and uses four real cases to show how the results complement one another. Routine cell counts and biochemistry are mainly screening tools; flow cytometry offers high sensitivity for detecting very small populations of abnormal cells; and molecular testing can be particularly useful in patients with known fusion genes or other genetic abnormalities. Integrating multiple test results is important for accurately identifying CNS leukemia and reducing the risk of missed disease and relapse.
Central nervous system leukemia (CNS leukemia) is one of the most common extramedullary manifestations of acute lymphoblastic leukemia (ALL).
Doctors commonly perform a lumbar puncture (spinal tap) to collect cerebrospinal fluid (CSF) and check for leukemia cells, helping determine whether the central nervous system is involved. It is important to remember, however, that CNS leukemia can also present as an intracranial mass, spinal cord involvement, or involvement of the eyes or cranial nerves.
Diagnosing CNS leukemia requires sensitive molecular and immunologic methods rather than relying on cell counts alone. Timely and accurate testing can help reduce the risk of relapse.
This article explains how CSF obtained through lumbar puncture is evaluated for CNS leukemia, and uses real cases to show why the different tests are important and how they complement one another.
CSF Tests and What They Tell Us
The main goal of CSF testing is to determine whether leukemia cells are present in the cerebrospinal fluid. In some patients, CSF testing can also help evaluate other central nervous system problems, such as infection or autoimmune encephalitis. Common tests include:
1. Routine CSF Analysis
Routine analysis includes assessing the appearance of the CSF - for example, whether it is clear and what color it is - as well as measuring white blood cells, red blood cells, mononuclear cells, and polymorphonuclear cells. Example reports:
Routine CSF analysis: normal
Routine CSF analysis: traumatic tap
Normally, CSF is clear and colorless, and the white blood cell count falls within the reference range. When leukemia cells are present, especially in large numbers, the fluid may appear pale yellow and the white blood cell count is often elevated. If blood enters the CSF sample and red blood cells are detected, the fluid may look red or pink; in this situation, the first step is to determine whether the blood was introduced by a traumatic lumbar puncture.
Infections can also raise the CSF white blood cell count and change the appearance of the fluid. When that happens, other tests are needed to help determine the cause.
2. CSF Biochemistry
This usually includes chloride, glucose, and total CSF protein. Example report:
CSF biochemistry: normal
Under normal circumstances, CSF biochemical values fall within their reference ranges. In patients with CNS leukemia, findings may include elevated protein and/or low chloride and/or low glucose. Similar changes can also occur with infection, so the results need to be interpreted together with other tests.
Routine CSF analysis and biochemistry are both basic tests performed with lumbar puncture. Because they can be affected by infection, chemotherapy-related changes, or a traumatic tap, they cannot confirm CNS leukemia on their own and are best used as initial screening tools.
3. CSF Cytomorphology
This test uses manual microscopic examination to classify the cells present in CSF. Example report:
Manual review allows the laboratory team to directly examine the cellular components in the CSF.
Its main advantage is that the findings can be visually clear and specific. However, because the test relies on manual examination, its sensitivity is relatively limited, so the result often needs to be interpreted together with other tests.
4. CSF Flow Cytometry
Principle: Flow cytometry identifies malignant cells by detecting characteristic combinations of antigens on the surface of leukemia cells. The principle is similar to immunophenotyping of bone marrow samples. Key feature:
Flow cytometry is highly sensitive and can detect very small populations of residual abnormal cells.
Example report:
CSF flow cytometry in a patient with acute promyelocytic leukemia (APL)
5. Molecular Testing of CSF
Principle: Molecular testing looks for leukemia-specific genetic markers - such as the BCR::ABL1 fusion gene or NPM1 variants - using PCR or next-generation sequencing (NGS). It is mainly applicable to patients with a known genetic abnormality, such as Ph-positive ALL or APL. It is used less broadly than immunophenotyping, but for a defined molecular marker it may offer even greater analytical sensitivity than flow cytometry.
Example report:
CSF fusion-gene testing in a patient with APL and a previous history of CNS leukemia
CSF cytology, flow cytometry, and genetic testing can also be used more broadly when evaluating hematologic diseases involving the central nervous system. In primary or secondary CNS hematologic disease, particularly when abnormalities are confined to the CNS, CSF may be one of the most important specimens available. A comprehensive workup can include broad flow-cytometric screening, molecular testing, and in selected cases even cytogenetic studies.
Patient Case Examples
1. Case 1
Routine CSF analysis and biochemistry were normal, but cytomorphology and flow cytometry detected CNS leukemia.
Patient: 23-year-old woman with mixed-phenotype acute leukemia. She had no clinical symptoms.
Routine CSF white blood cell count: 0
2. Case 2
Routine CSF findings were normal. CSF glucose and chloride were above the reference range, while cytomorphology and flow cytometry showed no abnormalities. CNS leukemia was detected only because quantitative testing for a fusion gene in CSF was positive.
Patient: 14-year-old boy with acute lymphoblastic leukemia.
3. Case 3
Routine CSF testing showed an elevated white blood cell count, while biochemistry was normal and cytomorphology, flow cytometry, and molecular testing were all negative. The elevated cells were considered reactive, and CNS leukemia was excluded. Patient:
24-year-old man with acute lymphoblastic leukemia and a ZBTB5-JAK2 fusion gene.
Routine CSF white blood cell count: 18, elevated
4. Case 4
Routine CSF testing showed an elevated white blood cell count, and all biochemical parameters were abnormal. Cytomorphology, flow cytometry, and molecular testing showed no evidence of leukemia. A CAR-T cell assay detected CAR-T cells in the CSF, supporting that the elevated cells represented CAR-T cells entering the central nervous system rather than CNS leukemia.
Patient: 38-year-old man with T-cell acute lymphoblastic leukemia, positive for a SET-CAN fusion gene, after CD7 CAR-T therapy.
Routine CSF white blood cell count: 52, elevated
Testing Strategy
For patients with hematologic malignancies undergoing lumbar puncture and CSF testing, several points are worth keeping in mind:
1. Tests Commonly Recommended for CSF
Basic tests: routine cell count, biochemistry (protein/glucose), cytomorphology (microscopic review of cell morphology), and flow-cytometric immunophenotyping.
Advanced tests: if a fusion gene or gene mutation has already been identified, related molecular testing may be added, such as testing for MLL rearrangements or TP53 mutations.
For patients with hematologic malignancies, the article recommends sending the above tests whenever CSF is collected by lumbar puncture.
2. Common Misunderstandings About the CSF White Blood Cell Count
A high white blood cell count does not necessarily mean CNS leukemia: infection, chemotherapy-related changes, or procedural trauma can also cause an increase.
A normal white blood cell count does not rule out CNS leukemia: some patients with relapse may have only a very small amount of disease detectable by flow cytometry or molecular testing, while routine CSF findings remain normal.
3. Why Are Lumbar Puncture and Intrathecal Therapy Needed?
Lumbar puncture and intrathecal therapy are important parts of the diagnostic and treatment process for patients with hematologic malignancies for several reasons:
Even when there is no CNS leukemia at the initial diagnosis, regular CSF monitoring remains important, particularly cytomorphology and flow-cytometric immunophenotyping. Intrathecal therapy can also be used to prevent or treat CNS leukemia. In clinical practice, relapse can occasionally occur only in the central nervous system, and patients may have no symptoms when it happens. Routine CSF testing may also appear unremarkable, while cytomorphology, flow cytometry, or molecular testing identifies disease. Conversely, normal CSF testing does not necessarily exclude every form of CNS involvement. If central nervous system disease is still suspected, additional evaluation such as brain MRI may be needed.
If you have questions about CSF testing or central nervous system leukemia, or would like advice based on your own condition, you can contact a specialist online through the Internet Hospital for an individualized consultation.
*This article is for general health education only and is not a substitute for professional medical advice. Please follow the recommendations of your treating physician.